Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0016
0.00 (0.00%)
Feb 12, 2026, 10:47 AM EST
Halberd Market Cap
Halberd has a market cap or net worth of $1.2 million as of February 12, 2026. Its market cap has decreased by -39.34% in one year.
Market Cap
1.20M
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 1.20M, a decrease of -54.11%. That is a compound annual growth rate of -4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.20M | 12.70% |
| Dec 31, 2025 | 1.06M | -58.29% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 1.66M |
| Carisma Therapeutics | 1.65M |
| ZyVersa Therapeutics | 1.62M |
| Exousia Pro | 1.54M |
| inTerra Resources | 1.49M |
| International Stem Cell | 1.32M |
| Sigyn Therapeutics | 1.20M |
| CERo Therapeutics Holdings | 1.20M |